Tatlı, A. M. Et Al. 2014. Treatment with capecitabine plus bevacizumab following induction treatment with FOLFIRI plus bevacizumab in metastatic colorectal carcinoma. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.7, no.8 , 2191-2196.

Tatlı, A. M., COŞKUN, H. Ş., Uysal, M., Arslan, D., Göksu, S. S., GUNDUZ, S. G., ... CAKAL, S.(2014). Treatment with capecitabine plus bevacizumab following induction treatment with FOLFIRI plus bevacizumab in metastatic colorectal carcinoma. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.7, no.8, 2191-2196.

Tatlı, ALİ Et Al. "Treatment with capecitabine plus bevacizumab following induction treatment with FOLFIRI plus bevacizumab in metastatic colorectal carcinoma," INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.7, no.8, 2191-2196, 2014

Tatlı, ALİ M. Et Al. "Treatment with capecitabine plus bevacizumab following induction treatment with FOLFIRI plus bevacizumab in metastatic colorectal carcinoma." INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.7, no.8, pp.2191-2196, 2014

Tatlı, A. M. Et Al. (2014) . "Treatment with capecitabine plus bevacizumab following induction treatment with FOLFIRI plus bevacizumab in metastatic colorectal carcinoma." INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.7, no.8, pp.2191-2196.

@article{article, author={ALİ MURAT Tatlı Et Al. }, title={Treatment with capecitabine plus bevacizumab following induction treatment with FOLFIRI plus bevacizumab in metastatic colorectal carcinoma}, journal={INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE}, year=2014, pages={2191-2196} }